Related Experiment Video
Updated: May 21, 2025

09:45
Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease
Published on: April 12, 2021
7.9K
Free-Floating Human Lung Organoids Derived from Induced Pluripotent Stem Cells
Bettina Budeus1, Chiara Kroepel1, Lisa Marie Stasch1
1Institute for Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|March 19, 2025
Summary
Researchers developed a simple method to create human lung organoids from induced pluripotent stem cells (iPSCs). This matrix-free approach advances in vitro lung disease modeling, offering a more animal-component-free alternative.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Respiratory Medicine
Background:
- Lung diseases pose a significant global health burden, driving demand for advanced research models.
- Current in vitro models, including lung organoids, are crucial for studying respiratory diseases.
- Existing methods for generating lung organoids can be complex and may involve animal-derived components.
Purpose of the Study:
- To present a straightforward, reliable protocol for generating human lung organoids.
- To develop an in vitro model system that minimizes or eliminates the need for animal-derived components.
- To facilitate advancements in basic and translational research for lung diseases.
Main Methods:
- Generation of lung organoids from induced pluripotent stem cells (iPSCs).
- Utilized a matrix-free protocol for organoid development.
- Detailed methodology for practical application in research settings.
Main Results:
- Successfully generated functional lung organoids using the described protocol.
- The method is practical, reliable, and does not require a supporting matrix.
- The protocol offers a step towards animal-origin and component-free in vitro modeling.
Conclusions:
- The presented matrix-free protocol provides a simplified and effective method for generating human lung organoids from iPSCs.
- This approach enhances the utility of organoids for lung disease research and modeling.
- The development represents a significant advancement for creating component-free in vitro models for respiratory research.

